UnitedHealth's leadership is showcasing confidence in the company's prospects as newly appointed CEO, Stephen Hemsley, makes a bold financial commitment. Hemsley has invested $25 million in the company by purchasing 86,700 shares at an average price of $288.57 each. This strategic move comes in the wake of a substantial 20% decline in UNH's stock price, coinciding with ongoing Department of Justice investigations.
After taking over the leadership of the Eden Prairie, Minnesota-based healthcare firm on Tuesday, abruptly replacing former CEO Andrew Witty, Hemsley added 86.7K UnitedHealth shares on Friday for $288.57 apiece on average.
Hemsley, who previously led the company from 2016 to 2017, has boosted his company holdings by ~8% to ~1.1M shares through the transaction valued at just above $25M, according to a regulatory filing submitted late Friday.
Meanwhile, UnitedHealth’s CFO John Rex has joined insider buying, adding about 17.2K UNH shares for $291.12 apiece on Friday, increasing his stake by ~9% to ~210.6K shares, in a deal valued at roughly $5M.
Their transactions followed several purchases by three UnitedHealth directors, who bought over $1.6M worth of UNH shares on Wednesday and Thursday as the stock fell amid its sudden CEO transition and a report about a DoJ criminal probe against the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.